Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

被引：0

作者：

Haude, Michael ^{[1
]}

Ince, Huseyin ^{[2
,3
]}

Kische, Stephan ^{[4
]}

Abizaid, Alexandre ^{[5
]}

Toelg, Ralph ^{[6
]}

Lemos, Pedro A. ^{[7
]}

Van Mieghem, Nicolas ^{[8
]}

Verheye, Stefan ^{[9
]}

von Birgelen, Clemens ^{[10
]}

Christiansen, Evald ^{[11
]}

Barbato, Emanuele ^{[12
]}

Neumann, Franz-Josef ^{[13
]}

Witzenbichler, Bernhard ^{[14
]}

Kaiser, Christoph ^{[15
]}

Eeckhout, Eric ^{[16
]}

Escaned, Javier ^{[17
]}

Garcia-Garcia, Hector ^{[18
]}

Waksman, Ron ^{[18
]}

机构：

[1] Lukaskrankenhaus Neuss, Neuss, Germany

[2] Univ Rostock, Vivantes Klinikum Friedrichshain & Urban, Berlin, Germany

[3] Univ Rostock, Dept Cardiol, Berlin, Germany

[4] Vivantes, Berlin, Germany

[5] Inst Dante Pazzanese Cardiol, Sao Paulo, SP, Brazil

[6] Segeberger Kliniken, Herzzentrum, Bad Segeberg, Germany

[7] Univ Sao Paulo, Fac Med, InCor, Sao Paulo, SP, Brazil

[8] Erasmus MC, Thoraxctr, Rotterdam, Netherlands

[9] Cardiovasc Ctr ZNA Middelheim, Antwerp, Belgium

[10] Thoraxcentrum Twente, Enschede, Netherlands

[11] Aarhus Univ Hosp, Aarhus, Denmark

[12] Aalst OLV Hosp, Cardiovasc Res Ctr, Aalst, Belgium

[13] Univ Heart Ctr Freiburg Bad Krozingen, Cardiol, Bad Krozingen, Germany

[14] Helios Amper Klinikum, Dachau, Germany

[15] Univ Hosp Basel, Basel, Switzerland

[16] Lausanne Univ Hosp, CH-1011 Lausanne, Switzerland

[17] Hosp Clin San Carlos, IdISSC, Madrid, Spain

[18] MedStar Washington Hosp Ctr, Washington, DC USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 72卷 / 13期

关键词：

D O I：

10.1016/j.jacc.2018.08.1152

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-63

引用

页码：B27 / B28

页数：2

共 40 条

[21] BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)-2 Year Clinical Results
Ruiz-Salmeron, Rafael
Lefevre, Thierry
Haude, Michael
Stangl, Karl
Slagboom, Ton
Neumann, Franz-Josef
Sabate, Manel
Macia, Jean Christophe
Richardt, Gert
Merkely, Bela
Goicolea, J.
Bilger, Johannes
Divchev, Dimitar
Barragan, Paul
Cook, Stephane
Witzenbichler, Bernhard
Windecker, Stephan
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B177 - B177
[22] BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)-5 Year Clinical Results
Slagboom, Ton
Lefevre, Thierry
Haude, Michael
Gross, Michael
Stangl, Karl
Neumann, Franz-Josef
Sabate, Manel
Richardt, Gert
Merkely, Bela
Goicolea, Javier
Barragan, Paul
Waksman, Ron
Windecker, Stephan
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B313 - B313
[23] Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions The SPIRIT II Trial
Claessen, Bimmer E.
Beijk, Marcel A.
Legrand, Victor
Ruzyllo, Witold
Manari, Antonio
Varenne, Olivier
Suttorp, Maarten J.
Tijssen, Jan G. P.
Miquel-Hebert, Karine
Veldhof, Susan
Henriques, Jose P. S.
Serruys, Patrick W.
Piek, Jan J.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (04) : 339 - 347
[24] Four-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions: The SPIRIT II Trial
Garg, Scot
Serruys, Patrick W.
Miquel-Hebert, Karine
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011, 77 (07) : 1012 - 1017
[25] Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial
Stone, Gregg W.
Midei, Mark
Newman, William
Sanz, Mark
Hermiller, James B.
Williams, Jerome
Farhat, Naim
Caputo, Ronald
Xenopoulos, Nicholas
Applegate, Robert
Gordon, Paul
White, Roseann M.
Sudhir, Krishnankutty
Cutlip, Donald E.
Petersen, John L.
CIRCULATION, 2009, 119 (05) : 680 - 686
[26] Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial
Xu, Bo
Dou, Kefei
Yang, Yuejin
Lv, Shuzheng
Wang, Lefeng
Wang, Haichang
Li, Zhanquan
Wang, Lei
Chen, Yundai
Huo, Yong
Li, Wei
Kirtane, Ajay J.
Gao, Runlin
EUROINTERVENTION, 2012, 8 (07) : 796 - 802
[27] BIOFLOW-VI: BIOTRONIK-Safety and Clinical PerFormance of the Drug ELuting Orsiro Stent in the Treatment of Subjects With de novo Coronary Artery Lesions-VI: 2 Years Clinical Results
Yang, Yue Jin
Xu, Biao
Waksman, Ron
Zhu, Ye
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B279 - B279
[28] Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study
Haude, Michael
Wlodarczak, Adrian
van der Schaaf, Rene J.
Torzewski, Jan
Ferdinande, Bert
Escaned, Javier
Iglesias, Juan F.
Bennett, Johan
Toth, Gabor
Joner, Michael
Toelg, Ralph
Wiemer, Marcus
Olivecrona, Goeran
Vermeersch, Paul
Garcia-Garcia, Hector M.
Waksman, Ron
ECLINICALMEDICINE, 2023, 59
[29] Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study
Fajadet, Jean
Wijns, William
Laarman, Gert-Jan
Kuck, Karl-Heinz
Ormiston, John
Baldus, Stephan
Hauptmann, Karl E.
Suttorp, Maarten D.
Drzewiecki, Janusz
Pieper, Michael
Schultheiss, Heinz-Peter
Mauri, Laura
EUROINTERVENTION, 2010, 6 (05) : 562 - 567
[30] First clinical experience with 17-estradiol-eluting BiodivYsio matrix LO Stent to prevent restenosis in de-novo native coronary arteries: Six-month clinical outcomes and angiographic follow-up from the EASTER trial
Abizaid, AA
New, G
Abizaid, AS
Costa, M
Vaz, V
Kipshidze, N
Staico, R
Fares, F
Mehran, R
Pinto, I
Roubin, G
Iyer, S
Moses, J
Leon, M
Sousa, A
Sousa, JEM
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 56A - 56A

← 1 2 3 4 →